GENVIP – Publications

Publications

Since 2007 GENVIP has published more than 430 publications

SURVEY BY TEDDY EUROPEAN NETWORK OF EXCELLENCE FOR PAEDIATRIC CLINICAL RESEARCH DEMONSTRATES POTENTIAL FOR EUROPE-WIDE TRIALS

Ruggieri L, Bonifazi D, Landi A, Bonifazi F, Bartoloni F, Costello M, Felisi MG, Gasthuys E, Godo A, Martinon Torres F, Nadal D, Nuytinck L, Rocchi F, Turner M, Ceci A

Pubmed Full article

Doi:

Acta paed

Factor de impacto:

Q2

Doi:

REACTIONS ON RE-EXPOSURE FOLLOWING NEGATIVE AND INCONCLUSIVE FOLLOW-UP FOOD CHALLENGES IN CHILDREN WITH ACUTE FPIES

Laura Argiz, Sonsoles Infante, Adrianna Machinena, Mariona Pascal, Luis Echeverria, Simona Barni, Teresa Garriga-Baraut, Stefania Arasi, Jose Domingo Moure, Alberto Gomez-Carballa, Federico Martinon-Torres, Robert J Boyle, Marta Vazquez-Ortiz, BIO-FPIES study network

Pubmed Full article

Doi:

J Allergy Clin Immunol Pract

Factor de impacto:

Q1

Doi:

ENFERMEDAD MENINGOCÓCICA: ¿PODEMOS PREDECIR LO IMPREDECIBLE?

Federico Martinón-Torresy Antoni Trillac

Pubmed Full article

Doi:

Med Clin

Factor de impacto:

Q3

Doi:

ROUTINE INFANT VACCINATION OF PNEUMOCOCCAL CONJUGATE VACCINES HAS DECREASED PNEUMONIA ACROSS ALL AGE GROUPS IN NORTHERN SPAIN

I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. Martinón Sanchez and F. Martinón-Torres

Pubmed Full article

Doi:

Hum Vaccine Immunother

Factor de impacto:

Q2

Doi:

QUADRIVALENT INFLUENZA VACCINE PREVENTS ILLNESS AND REDUCES HEALTHCARE UTILIZATION ACROSS DIVERSE GEOGRAPHIC REGIONS DURING FIVE INFLUENZA SEASONS. A RANDOMIZED CLINICAL TRIAL

Ghassan Dbaibo, Arshad Amanullah, Carine Claeys, Allen Izu, Varsha K. Jain, Pope Kosalaraksa, Luis Rivera, Jyoti Soni, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Jasur Danier, Alfonso Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, Thanyawee Puthanakit, Renata Ruzkova, Iwona Sadowska-Krawczenko Henryk Szymanski, Angels Ulied, Wayne Woo, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group

Pubmed Full article

Doi:

Pediatr Infect Dis J

Factor de impacto:

Doi:

USE OF THE WHO ACCESS, WATCH, AND RESERVE CLASSIFICATION TO DEFINE PATTERNS OF HOSPITAL ANTIBIOTIC USE (AWARE):AN ANALYSIS OF PAEDIATRIC SURVEY DATA FROM 56 COUNTRIES

1Yingfen Hsia, Brian R Lee, Ann Versporten, Yonghong Yang, Julia Bielicki, Charlotte Jackson, Jason Newland, Herman Goossens, Nicola Magrini, Mike Sharland on behalf of the GARPEC and Global-PPS networks (Federico Martinon Torres, Antonio Justicia

Pubmed Full article

Doi:

Factor de impacto:

Doi:

A QPCR EXPRESSION ASSAY OF IFI44L GENE DIFFERENTIATES VIRAL FROM BACTERIAL INFECTIONS IN FEBRILECHILDREN

Alberto Gómez-Carballa, Miriam Cebey-López, Jacobo Pardo-Seco, Ruth Barral-Arca, Irene Rivero-Calle, Sara Pischedda, María José Currás-Tuala1, José Gómez-Rial, Francisco Barros, Federico Martinón-Torres & Antonio Salas

Pubmed Full article

Doi:

Sci Rep

Factor de impacto:

Doi:

MENINGOCOCCAL GROUP B VACCINE FOR THE PREVENTION OF INVASIVE MENINGOCOCCAL DISEASE CAUSED BY NEISSERIA MENINGITIDIS SEROGROUP B

Rivero Calle, I; Raguindin PF; Gómez Rial, J; Rodríguez-Tenreiro, C; Martinón-Torres, F.

Pubmed Full article

Doi:

Infection and Drug Resistance

Factor de impacto:

Q1

Doi:

BACTEREMIA IN CHILDHOOD LIFE-THREATENING INFECTIONS IN URBAN GAMBIA: EUCLIDS IN WEST AFRICA

F Secka, J A Herberg, I Sarr, S Darboe, G Sey, M Saidykhan, M Wathuo, M Kaforou, M Antonio, A Roca, S M A Zaman, M Cebey-López, N P Boeddha, S Paulus, D S Kohlfürst, M Emonts, W Zenz, E D Carrol, R de Groot, L Schlapbach, F Martinon-Torres, K Bojang, M Levin, M van der Flier, S T Anderson on behalf of the EUCLIDS Consortium

Pubmed Full article

Doi:

Open Forum Infectious Diseases

Factor de impacto:

Q2

Doi:

BIOGEOGRAPHICAL INFORMATIVENESS OF Y-STR HAPLOTYPES

Pardo-Seco, J; Gomez-Carballa, A; Bello, X ; Martinon-Torres, F; Salas, A

Pubmed Full article

Doi:

Science Bulletin

Factor de impacto:

Q1

Doi:

A STRATEGY TARGETING MONOCYTE-MACROPHAGE DIFFERENTIATION TO AVOID PULMONARY COMPLICATIONS IN SARS-COV2 INFECTION

J.Gómez-Rial, F.Martinón-Torres

Clin Immunol

Factor de impacto:

Q2

Doi:

Pubmed Full article

MAPPING GENOME VARIATION OF SARS-COV-2 WORLDWIDE HIGHLIGHTS THE IMPACT OF COVID-19 SUPER-SPREADERS

Alberto Gómez-Carballa, Xabier Bello, Jacobo Pardo-Seco, Federico Martinón-Torres, Antonio Salas

bioRxiv

Factor de impacto:

Q1

Doi:

Pubmed Full article

CLINICAL CHARACTERISTICS OF 58 CHILDREN WITH A PEDIATRIC INFLAMMATORY MULTISYSTEM SYNDROME TEMPORALLY ASSOCIATED WITH SARS-COV-2

Elizabeth Whittaker; Alasdair Bamford; Julia Kenny; Myrsini Kaforou; Christine E. Jones; Priyen Shah; Padmanabhan Ramnarayan; Alain Fraisse; Owen Miller; Patrick Davies; Filip Kucera; Joe Brierley; Marilyn McDougall; Michael Carter; Adriana Tremoulet; Chisato Shimizu Jethro Herberg; Jane C. Burns; Hermione Lyall; Michael Levin; for the PIMS-TS Study Group and EUCLIDS and PERFORM Consortia (Federico Martinón-Torres)

JAMA

Factor de impacto:

Q1

Doi:

Pubmed Full article

RNA-SEQ DATA-MINING ALLOWS THE DISCOVERY OF TWO LONG NON-CODING RNA BIOMARKERS OF VIRAL INFECTION IN HUMANS

Ruth Barral-Arca, Alberto Gómez-Carballa, Miriam Cebey-López, María José Currás-Tuala, Sara Pischedda, Sandra Viz-Lasheras, Xabier Bello, Federico Martinón-Torres and Antonio Salas

International J Molecular Sciences

Factor de impacto:

Q1

Doi:

Pubmed Full article

COST OF RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED ACUTE LOWER RESPIRATORY INFECTION MANAGEMENT IN YOUNG CHILDREN AT THE REGIONAL AND GLOBAL LEVEL: A SYSTEMATIC REVIEW AND META-ANALYSIS.

Zhang S, Akmar LZ, Bailey F, Rath BA, Alchikh M, Schweiger B, Lucero MG, Nillos LT, Kyaw MH, Kieffer A, Tong S, Campbell H, Beutels P, Nair H; RESCEU Investigators

J Infect Dis.

Factor de impacto:

Q1

Doi:

Pubmed Full article

IMMUNOLOGICAL AND INFLAMMATORY BIOMARKERS OF SUSCEPTIBILITY AND SEVERITY IN ADULT RESPIRATORY SYNCYTIAL VIRUS INFECTIONS.

Wiseman DJ, Thwaites RS, Drysdale SB, Janet S, Donaldson GC, Wedzicha JA, Openshaw PJ; RESCEU Investigators

J Infect Dis.

Factor de impacto:

Q1

Doi:

Pubmed Full article

LOW SENSITIVITY OF BINAXNOW RSV IN INFANTS.

Zuurbier RP, Bont LJ, Langedijk AC, Hamer M, Korsten K, Drysdale SB, Snape MD, Robinson H, Pollard AJ, Martinón-Torres F, Rodríguez-Tenreiro Sánchez C, Gómez-Carballa A, Dacosta-Urbieta AI, Heikkinen T, Cunningham S, van Houten MA, Wildenbeest JG; RESCEU Investigators .

J Infect Dis.

Factor de impacto:

Q1

Doi:

Pubmed Full article

PROTECTING THE MOST VULNERABLE AGE GROUP: A REVIEW OF MENACWY-TT IMMUNOGENICITY AND SAFETY IN INFANTS.

Martinón-Torres F, Serra L, Safadi MAP.

Expert Rev Vaccines

Factor de impacto:

Q2

Doi:

Pubmed Full article

PATHWAY TOWARDS AN IDEAL AND SUSTAINABLE FRAMEWORK AGREEMENT FOR THE PUBLIC PROCUREMENT OF VACCINES IN SPAIN: A MULTI-CRITERIA DECISION ANALYSIS.

Zozaya González N, Alcalá Revilla B, Arrazola Martínez P, Chávarri Bravo JR, Cuesta Esteve I, García Rojas A, Martinón-Torres F, Redondo Margüello E, Rivero Cuadrado A, Tamames Gómez S, Villaseca Carmena J, Hidalgo-Vega A

Hum Vaccine Immunother

Factor de impacto:

Q2

Doi:

Pubmed Full article

WHOLE-EXOME SEQUENCING FOR THE IDENTIFICATION OF RARE VARIANTS IN PRIMARY IMMUNODEFICIENCY GENES IN CHILDREN WITH SEPSIS - A PROSPECTIVE POPULATION-BASED COHORT STUDY

Alessandro Borghesi, Johannes Trück, Samira Asgari, Vanessa Sancho-Shimizu, Philipp KA Agyeman, Evangelos Bellos, Eric Giannoni, Martin Stocker, Klara M Posfay-Barbe, Ulrich Heininger, Sara Bernhard-Stirnemann, Anita Niederer-Loher, Christian R Kahlert, Giancardlo Natalucci, Christa Relly, Thomas Riedel, Claudia E Kuehni, Christian W. Thorball, Nimisha Chaturvedi, Federico Martinon-Torres, Taco W Kuijpers, Lachlan Coin, Victoria Wright, Jethro Herberg, Michael Levin, Christoph Aebi, Christoph Berger, Jacques Fellay, Luregn J Schlapbach, for the EUCLIDS consortium and the Swiss Paediatric Sepsis Study

Clin Infect Dis

Factor de impacto:

Q1

Doi:

Pubmed Full article

GENVIP is a research group dedicated to the study of infectious diseases and the development of vaccines using Omics tools.

The team is based in Santiago de Compostela, a historic World Heritage city with great cultural wealth and a long-established university tradition. The research group is part of the Health Research Institute of Santiago de Compostela [Instituto de Investigación Sanitaria de Santiago (IDIS)], an institution that brings together the strengths of the University of Santiago and the University Clinical Hospital of Santiago de Compostela.

Covid-19; parallel sequencing; NGS; exomes; whole-genome sequencing; gene expression; RNAseq; nanostring; proteomics; proteomics